	Mar 2025	Dec 2024	Mar 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	38.69	30.52	30.60	26.8%	26.4%
Operating Profit Qtr	8.18	5.00	4.16	63.6%	96.6%
Net Profit Qtr	1.99	4.57	1.80	-56.5%	10.6%
Earning Per Share Adjusted latest Qtr	0.42	0.97	0.38	-56.7%	10.5%

* Standalone data

Detailed Results

Kimia Biosciences Ltd.

28 May 2025

48.27

-2.97%

Company Update

Kimia Biosciences Ltd - 530313 - Newspaper Publication Of Financial Results As Per Regulation 30 Of …

BSE India

Newspaper Publication of Financial Results for the quarter and financial year ended on 31st Mrach,2025 as per Regulation 30 of Securities Exchange Board of India,2015

pdf

Kimia Biosciences Ltd.

26 May 2025

48.27

-2.97%

Corp. Note

Kimia Biosciences Ltd - 530313 - Integrated Filing (Financial)

BSE India

Integrated Filing (Financial) for the quarter and the financial year ended on 31st March 2025

pdf

Kimia Biosciences Ltd.

26 May 2025

48.27

-2.97%

Board Meeting

Kimia Biosciences Ltd - 530313 - Board Meeting Outcome for Outcome Of The Financials In The …

BSE India

Outcome of the Financials in the Board Meeting

pdf

Kimia Biosciences Ltd.

23 May 2025

48.27

-2.97%

Corp. Note

Kimia Biosciences Ltd - 530313 - Format of the Initial Disclosure to be made by an …

BSE India

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyKimia Biosciences Ltd 2CIN NO.L24239HR1993PLC032120 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 10.37 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: CS PALLAVI GARG Designation: COMPANY SECRETARY EmailId: compliance.kimiabiosciences@gmail.com Name of the Chief Financial Officer: Rakesh Chetani Designation: CFO EmailId: compliance.kimiabiosciences@gmail.com Date: 23/05/2025 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

pdf

Kimia Biosciences Ltd.

21 May 2025

48.27

-2.97%

Board Meeting

Kimia Biosciences Ltd - 530313 - Board Meeting Intimation for Approval Of Audited Financials For The …

BSE India

Kimia Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2025 ,inter alia, to consider and approve approval of audited financials for the quarter and financial year ended on 31st march 2025

pdf

Kimia Biosciences Ltd.

05 May 2025

48.27

-2.97%

Board Meeting

Kimia Biosciences Ltd - 530313 - Board Meeting Outcome for Outcome Of Board Meeting Held On …

BSE India

Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of Kimia Biosciences Limited at its meeting held today, i.e., Monday, 05th May 2025, inter alia, considered and approved the matter, Redemption of Preference Shares.

pdf

Kimia Biosciences Ltd.

01 May 2025, 06:08PM

48.27

-2.97%

Board Meeting

Kimia Biosciences Ltd - 530313 - Board Meeting Intimation for Payment To Redeemable Preference Shares

BSE India

Kimia Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/05/2025 ,inter alia, to consider and approve Intimation for the Board Meeting to be held on Monday, 05th May 2025 for the Payment to Redeemable Preference Shares

pdf

Is Kimia Biosciences Ltd. worth buying?

14 Votes:

Buy 71.43%

Sell 7.14%

Hold 21.43%